World Ovarian Cancer Day brings together ovarian cancer organisations across the globe every year on May 8 to raise awareness.
On this day, ovarian cancer awareness organizations from around the world united to educate their communities about ovarian cancer and its symptoms. For women living with the disease, and their families and friends, World Ovarian Cancer Day has built and will continue to build a sense of solidarity in the fight against the disease. (World Ovarian Cancer Day statement)
Ovarian cancer has the lowest survival rate of all gynaecologic cancers and is characterized around the world by a lack of awareness of symptoms and late stage diagnosis.
Symptoms are often misdiagnosed, as they can be confused with symptoms of other less severe illnesses, particularly gastrointestinal complaints. Many women go untreated until the disease has spread within the pelvis and abdomen and at this late stage ovarian cancer is difficult to treat and is often fatal.
Ovarian cancer is generally referred to as a silent killer and is diagnosed annually in nearly a quarter of a million women globally and is responsible for 140’000 deaths each year.
In 2012, it has been diagnosed in 65,538 women on the European continent.
Furthermore, about 1.4% of women in the general population will develop ovarian cancer sometime during their lives and approximately 15% of cases of ovarian cancer are due to inherited mutations which cause increased risk.
According to the Ovarian Cancer National Alliance:
Having an inherited mutation in one of two genes called breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2) increases a woman’s risk for both breast and ovarian cancer. These genes are responsible for about 5% to 10% of all ovarian cancers.
The Breast Cancer (BRCA) 1 and 2 genes were first identified in the early 1990’s and represent the most significant and well characterized genetic risk factors identified for breast and ovarian cancers.
Today, leading scientists suggest that all women over the age of 30 should be screened for BRCA1/2 mutations as part of their routine medical care.
To learn more about the early detection of BRCA mutations, read about Serenity: Genoma’s Breast and Ovarian cancer risk test.
The first World Ovarian Cancer Day took place May 8th, 2013.
During this particular day, join the global movement to raise awareness about ovarian cancer starting with the people in our own lives.
Genoma strongly believes in cancer research, and considers scientific and medical support as one of its core values.
Genoma continually aids in development of new genetic predictive processes by providing genetic information towards this cause, with the aim in developing precision diagnostics of genetic mutations leading to cancer formation and using this genetic information to help in developing personalized therapies which are most effective.